We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
+4.09%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$3.28B
AUM Growth
+$15.5M
Cap. Flow
-$49.2M
Cap. Flow %
-1.5%
Top 10 Hldgs %
21.61%
Holding
3,195
New
52
Increased
439
Reduced
901
Closed
65

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$5.36M
2
PINS icon
Pinterest
PINS
+$3.87M
3
TSLA icon
Tesla
TSLA
+$3.31M
4
TTWO icon
Take-Two Interactive
TTWO
+$2.99M
5
VIK icon
Viking Holdings
VIK
+$2.63M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$18.5M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$15.2M
3
FIX icon
Comfort Systems
FIX
+$5.8M
4
NVDA icon
NVIDIA
NVDA
+$5.76M
5
AAPL icon
Apple
AAPL
+$5.15M

Sector Composition

Rank Sector Weight
1 Technology 25.02%
2 Industrials 9.61%
3 Consumer Discretionary 9.1%
4 Financials 9.03%
5 Healthcare 7.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NATH icon
2601
Nathan's Famous
NATH
$397M
$21.8K ﹤0.01%
233
IHY icon
2602
VanEck International High Yield Bond ETF
IHY
$43.3M
$21.8K ﹤0.01%
990
RLGT icon
2603
Radiant Logistics
RLGT
$400M
$21.7K ﹤0.01%
3,434
JCAP
2604
Jefferson Capital
JCAP
$1.3B
$21.7K ﹤0.01%
971
USMV icon
2605
iShares MSCI USA Min Vol Factor ETF
USMV
$24.4B
$21.7K ﹤0.01%
230
+1
+0.4% +$94
LENZ
2606
LENZ Therapeutics
LENZ
$158M
$21.6K ﹤0.01%
1,351
FRAF icon
2607
Franklin Financial Services
FRAF
$289M
$21.5K ﹤0.01%
428
DMAC icon
2608
DiaMedica Therapeutics
DMAC
$369M
$21.5K ﹤0.01%
2,697
STLN
2609
Starling Oncology, Inc. Common Stock
STLN
$644M
$21.5K ﹤0.01%
6,026
HLLY icon
2610
Holley
HLLY
$384M
$21.4K ﹤0.01%
5,177
SNWV
2611
SANUWAVE Health Inc
SNWV
$46.2M
$21.4K ﹤0.01%
716
ARDT
2612
Ardent Health
ARDT
$1.57B
$21.3K ﹤0.01%
2,413
CCRN
2613
DELISTED
Cross Country Healthcare
CCRN
$21.2K ﹤0.01%
2,614
VMD icon
2614
Viemed Healthcare
VMD
$353M
$20.9K ﹤0.01%
2,819
BLZE icon
2615
Backblaze
BLZE
$1.2B
$20.9K ﹤0.01%
4,475
JELD icon
2616
JELD-WEN Holding
JELD
$164M
$20.8K ﹤0.01%
8,463
AGL icon
2617
Agilon Health
AGL
$1.45B
$20.8K ﹤0.01%
1,209
NGNE icon
2618
Neurogene
NGNE
$740M
$20.8K ﹤0.01%
1,009
CZFS icon
2619
Citizens Financial Services
CZFS
$399M
$20.8K ﹤0.01%
364
MVIS icon
2620
Microvision
MVIS
$111M
$20.7K ﹤0.01%
1,670
PANL icon
2621
Pangaea Logistics
PANL
$477M
$20.7K ﹤0.01%
3,008
HWBK icon
2622
Hawthorn Bancshares
HWBK
$276M
$20.7K ﹤0.01%
593
VGIT icon
2623
Vanguard Intermediate-Term Treasury ETF
VGIT
$42.4B
$20.7K ﹤0.01%
345
+300
+667% +$18K
ACH
2624
Accendra Health
ACH
$93.1M
$20.7K ﹤0.01%
7,381
BKTI icon
2625
BK Technologies
BKTI
$292M
$20.7K ﹤0.01%
277

Similar funds

Ameritas Investment Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Ameritas Investment Partners held 3,195 positions worth $3.28B, up 0.47% from $3.27B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q4 2025: portfolio turnover was 3.7%. Ameritas Investment Partners opened 52 new positions and exited 65, leaving the 3,195-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q4 2025 buy was Pinterest: 134,288 shares worth $3.48M.
  • Ameritas Investment Partners added most to Meta Platforms (Facebook) in Q4 2025, an estimated $5.36M increase.
  • Ameritas Investment Partners's biggest Q4 2025 reduction was Broadcom, cutting an estimated $18.5M.
  • Ameritas Investment Partners fully exited Light & Wonder in Q4 2025, selling an estimated $1.32M.
  • Ameritas Investment Partners's ten largest holdings make up 22% of its $3.28B portfolio in Q4 2025.
  • Ameritas Investment Partners opened 52 new positions and closed 65 in Q4 2025.
  • Ameritas Investment Partners's portfolio value rose 0.47% quarter-over-quarter to $3.28B.

Based on Ameritas Investment Partners's 13F filing for Q4 2025, filed 11 Feb 2026.